Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
1
Laboratory-identified Event (LabID) Module
for Long-term Care Facilities (LTCFs)
Addendum to the 2019 Laboratory-identified Event (LabID) Modulefor Long-term Care Facilities (LTCFs) presentation to reflect changes made beginning January 1, 2020.
What’s New in 2020?
• December 2019 newsletter• https://www.cdc.gov/nhsn/ltc/newsletters/index.
html
• LTCF module web-pages under the protocol tab
• Blast e-mail sent to NHSN users• NHSN version 9.4 Release Notes
(12/11/19)
Where can I find a list of the updates?
All positive results from specimens collected while the resident was receiving care within the LTCF must be reported for the participating events (C. difficile and individual MDROs).
What’s New in 2020?LabID Event (MDRO/CDI) Reporting
What’s New in 2020?CDI & MDRO LabID Event Key Points
ALL CDI & MDRO LabID Events must be submitted to NHSN. Includes:
• Duplicate CDI events with positive laboratory assays. • Residents with prior history of CDI or when the specimen was collected within
the first three days of admission to the LTCF. Excludes:
• MDRO tests related to active surveillance testing.
CDI & MDRO LabID Event rules apply to specimens collected while the resident was physically housed in the reporting LTCF or when a resident had a specimen collected during a brief visit to an outpatient setting, such as an ED or medical clinic.
What’s New in 2020?CDI & MDRO LabID Key Points – cont’d
Laboratory results obtained before a resident’s admission to the LTCF or during an admission in another facility should not be submitted as a CDI or MDRO LabID Event for the reporting LTCF.
If a specimen is collected while the resident is receiving care in an ED or OP setting, the Resident Care Location and Primary Resident Service Type should indicate the resident’s primary LTCF location and service type prior to the ED or OP visit.
When performing LabID Event reporting for CDI or MDRO, the facility must identify and report from all locations within the LTCF, referred to as FacWideIN.
Example Scenario – Should I Report Case as LabID Event?
Mr. T is a resident in your LTCF. On March 1st, he was transferred to the local ED for evaluation of diarrhea and fever. While in the ED, a loose stool specimen was collected and tested positive for C. difficile toxin. He received IV fluids and was transferred back to the LTCF the next calendar day, on March 2nd.
YES - Since the specimen was collected in the ED and Mr. T returned to the LTCF within 2 calendar days, the specimen collected in the ED should be submitted to NHSN as a CDI LabID Event for the LTCF.
Example Scenario – Should I Report Case as LabID Event?
Mrs. Anttila is admitted to your skilled nursing facility for rehab following a motor vehicle accident. According to her chart, she recently tested positive for multidrug resistant acinetobacter and was admitted to your facility on antibiotics.
While reviewing her chart, you also notice that a nasal swab was obtained as part of your MRSA active surveillance program. The culture was positive.
NO - You do not submit an MDR-Acinetobacter LabID Event for Mrs. Anttila since she was not tested while physically bedded in your LTCF and the positive MRSA swab was obtained as part of an active surveillance program.
Example Scenario – Should I Report Case as LabID Event?
Ms. Smith was admitted to your LTCF today, on May 1. According to her chart she was recently treated for VRE in a surgical wound but continues to have episodes of pain and copious discharge. The attending physician ordered a culture of the wound and the specimen was collected on the following day, on May 2. The results were positive for VRE, so a VRE LabID Event was submitted to NHSN for Ms. Smith.
Over the next several days, Ms. Smith’s condition seemed to worsen, as she developed a fever that would not respond to medication. A blood, urine, and wound culture were ordered. The specimens were collected on May 10 and came back with the following results: Blood +VRE; Wound +VRE and +MRSA; Urine +VRE. A LabID Event was entered for each MDRO: (1) VRE-Blood; (2) VRE – Wound; (3) MRSA Wound: and VRE-Urine.
YES – All LabID events should be entered for May 2nd and May 10th and NHSN will determine duplicate events, excluding them from calculated rates.
Categorizations of LabID Events
The NHSN application will assign each submitted positive specimen as either a duplicate or non-duplicate specimen based on the most recent positive specimen submitted in NHSN.
Duplicates will appear and marked as “duplicate” on the line list. Important Notes:
– Only non-duplicate LabID events will be included in NHSN calculated rates.– NHSN method for categorizing non-duplicate MDRO blood sources is
different compared to non-blood specimen sources.
Duplicate vs Non-duplicate – Who determines?
Example Scenario – Duplicate or Non-duplicate?
A new resident, Ms. T complained of burning during urination on June 12th, and on June 15th a urine culture specimen was collected and tested positive for MRSA. A MRSA LabID Event was entered for June 15th.
NHSN categorized the event as non-duplicate MRSA LabID Event since it was the first MRSA reported for Ms. T for the calendar month of June.
Example Scenario – Duplicate or Non-duplicate?
A week later, Ms. T spiked a high fever in which a blood culture was collected and positive for MRSA. A MRSA LabID event was entered for June 22. She had not had a reported positive MRSA blood isolate in the past 2 weeks (<15 calendar days).
NHSN categorized the MRSA blood as a non-duplicate MRSA LabID Event.
Example Scenario – Duplicate or Non-duplicate?
On July 2, another blood culture was collected from Ms. T. It returned positive for MRSA. A MRSA LabID Event was submitted to NHSN for July 2. Since this was the first MRSA positive isolate in a new calendar month, NHSN categorized the MRSA blood as a non-duplicate MRSA LabID Event.
On July 10, a urine culture and a blood culture were collected from Ms. T. Both specimens were positive for MRSA, and therefore reported as two individual MRSA LabID Events (one for the urine and one for the blood).
NHSN categorized both LabID Events as duplicate events. The MRSA urine since it was not the first MRSA specimen for Ms. T in the month of July; and the MRSA blood since it was less than 15 days since the last MRSA blood was reported to NHSN.
13
2019 Presentation, Slide 7
2019 Rules for Surveillance and Reporting for LabID Event Module
Surveillance must occur for all resident care locations in the facility—referred to as facility-wide inpatient or FacWideIN.
Must report positive non-duplicate test results for specimens collected from a resident in your facility at the time of specimen collection.
AND Specimens collected during a brief outpatient (OP) visit to an emergency
department (ED) or clinic/physician’s office if:
The resident returns back to your facility on same calendar day of the OP visit or the next calendar day
Note: There should be no change in current admission date
Slide 7 from 2019 slides
15
2020 Updates for Slide 7
16
When participating in the LabID Event Module, ALL positive LabID Events from specimens collected while the resident was receiving care within the LTCF must be submitted to NHSN, including duplicate LabID Events.
This new rule applies to all participating LabID events, including C. difficile and individual MDROs.
Note: The purpose of this change is to reduce the burden on users for determining which LabID events are considered as a reportable non-duplicate LabID event. NHSN will remove the duplicate specimens from calculated rates.
New for 2020 Surveillance and Reporting
Updated Slide 7 from 2019 slides
What’s New in 2020?
As a Reminder…..CDI & MDRO LabID Event Key Points
ALL CDI & MDRO LabID Events must be submitted to NHSN. Includes:
• Duplicate CDI events with positive laboratory assays. • Residents with prior history of CDI or when the specimen was collected within
the first three days of admission to the LTCF. • Residents with clinically positive MDRO isolates
Excludes:• MDRO test results related to active surveillance testing.
CDI & MDRO LabID Event rules apply to specimens collected while the resident was physically housed in the reporting LTCF or when a resident had a specimen collected during a brief visit to an outpatient setting, such as an ED or medical clinic.
18
2019 Presentation, Slide 9
2019 Monthly Participation Requirements
A NHSN Monthly Reporting Plan must be completed for each calendar month in which a facility plans to enter data into the NHSN.
LabID event surveillance must occur for the entire calendar month for the selected events/organisms
Submit all non-duplicate positive specimens to NHSN (numerator data)
Summary Data For each participating month, the facility must report the required denominator data
Resolve “Alerts”, if applicableSlide 9 from 2019 slides
20
2020 Updates for Slide 9
2020 Monthly Participation Requirements
A NHSN Monthly Reporting Plan must be completed for each calendar month in which a facility plans to enter data into the NHSN.
LabID event surveillance must occur for the entire calendar month for the selected events/organisms
Submit all positive CDI and clinical MDRO specimens for participating organisms to NHSN (numerator data)
Summary Data For each participating month, the facility must report the required denominator data
Resolve “Alerts”, if applicable Updated Slide 9 for 2020
22
2019 Presentation, Slide 14
2019 Rules Keep in mind the following………. Facility wide surveillance is required, which means surveillance must occur in all
resident care locations.
Testing performed on unformed/loose stool specimens (conforms to the shape of the container).
Positive tests collected before a resident’s admission to the LTCF or during an admission in another facility are excluded.
Non-duplicate laboratory results collected from an ED or other OP setting must be included if:
The resident returns to the LTCF on the calendar day of transfer to the OP setting or the following calendar day (specifically, there is no change in current admission date for LTCF)
Slide 14 from 2019 slides
24
2020 Updates for Slide 14
Update for 2020Keep in mind the following………. Facility wide surveillance is required, which means surveillance must occur in all
resident care locations.
Testing performed on unformed/loose stool specimens (conforms to the shape of the container).
Positive tests collected before a resident’s admission to the LTCF or during an admission in another facility are excluded.
Duplicate and non-duplicate laboratory results collected from an ED or other OP setting must be included if:
The resident returns to the LTCF on the calendar day of transfer to the OP setting or the following calendar day (specifically, there is no change in current admission date for LTCF)
Updated Slide 14 from 2019 slides
26
2019 Presentation, Slide 15
27
Common Terms and Definitions used in LabID Event Module
C. difficile positive laboratory assay: Unformed/loose stool that tests positive for C. difficile toxin A and/or B, (includes molecular assays [PCR] and/or toxin assays) OR A toxin-producing C. difficile organism detected by culture or other laboratory means.
Duplicate C. difficile positive laboratory assay: Any C. difficile toxin positive lab result collected from the same resident, while being cared for in your facility, following a previous C. difficile positive laboratory assay within the past 14 days.
CDI LabID Event: A non-duplicate C. difficile positive laboratory assay. Slide 15 from 2019 slides
28
2020 Updates for Slide 15
29
Update for 2020Common Terms and Definitions used in LabID Event Module CDI Laboratory-identified (LabID) Event: (1) C. difficile positive laboratory
assay collected from a resident while physically located in the LTCF at the time of specimen collection; or (2) C. difficile positive laboratory assay collected from a resident during a brief outpatient (OP) visit (not admission) to an emergency department (ED) or medical office when the resident returns to the LTCF on the same calendar day or the next calendar day (see Settings).
C. difficile positive laboratory assay: (1) An unformed/loose stool that tests positive for C. difficile toxin A and/or B. This includes molecular assays (PCR) and/or toxin assays; or (2) A toxin-producing C. difficile organism detected in an unformed/loose stool sample by culture or other laboratory means.
Updated Slide 15 from 2019 slides
30
Update for 2020Common Terms and Definitions used in LabID Event Module Duplicate CDI Laboratory-identified (LabID) Event: (1) C. difficile positive
laboratory assay collected from a resident while physically housed in the LTCF at the time of specimen collection when the resident had a previous CDI LabID Event submitted from the reporting facility within the past two weeks (specifically, less than 15 days); OR (2) C. difficile positive laboratory assay collected from a resident during a brief outpatient (OP) visit (not admission) to an emergency department (ED) or medical office when the resident returns to the LTCF on the same calendar day or the next calendar day (see Settings) when the resident had a previous CDI LabID Event submitted from the reporting facility within the past two weeks (specifically, less than 15 days).
NEW for 2020: LTCFs must submit all CDI LabID Events to NHSN, including duplicate CDI events with positive laboratory assays.
Updated Slide 15 from 2019 slides
31
2019 Presentation, Slide 16
32
Figure 1 - C. difficile Test Result Algorithm for Laboratory-identified (LabID) Events
Slide 16 from 2019 slides
33
2020 Updates for Slide 16
34
Figure 1 - C. difficile Test Result Algorithm for Laboratory-identified (LabID) EventsUpdate for 2020
LTCFs must submit all CDI LabID Events to NHSN, including duplicate CDI events with positive laboratory assays.
Updated Slide 16 from 2019 slides
35
2019 Presentation, Slide 20
36
What Specimens Should NOT be Submitted to NHSN as a CDI LabID Event?
Negative C. difficile laboratory assay lab results
Specimens collected during an admission in another healthcare facility
Duplicate positive results, defined as the same resident having a positive C. difficile lab result in the previous 14 days, when that specimen was collected in your facility or OP setting (ED or clinic)
Slide 20 from 2019 slides
37
2020 Updates for Slide 20
38
What Specimens Should NOT be Submitted to NHSN as a CDI LabID Event?
Negative C. difficile laboratory assay lab results
Specimens collected during an admission in another healthcare facility
Updated Slide 20 from 2019 slides
Update for 2020
39
2019 Presentation, Slide 23
40
Categorization of CDI LabID Events
NHSN will analyze data that have been entered into the application.
This includes categorizing all CDI LabID events to determine if the event is
Community onset (CO) Long term care facility onset (LO)
Acute care transfer long term care facility onset (ACT-LO) AND If the event is incident or recurrent
Slide 23 from 2019 slides
41
2020 Updates for Slide 23
42
Categorization of CDI LabID Events NHSN will analyze data that have been entered into the application.
Duplicate CDI LabID Events will appear in the NHSN line list and will be marked as a “duplicate”.
Duplicate CDI LabID Events will be excluded from rate calculations.
Categorizing all non-duplicate CDI LabID events to determine if the event is
Community onset (CO) Long term care facility onset (LO)
Acute care transfer long term care facility onset (ACT-LO) AND If the event is incident or recurrent
Update for 2020
Updated Slide 23 from 2019 slides
43
2019 Presentation, Slide 29
Let’s Review!
Long-term Care Facility-onset (LO)
Resident ID
Current AdmissionDate
SpecimenCollection Date
Previous positive C. diff result date
Submit as CDI LabID Event
10 2/1/19 2/2/19 none11 2/15/19 2/25/19 none12 2/1/19 2/1/19 none10 2/1/19 2/10/19 2/2/1913 2/20/19 2/17/19 none11 3/1/19 3/7/19 2/25/1910 2/1/19 2/18/19 2/10/19
YES
YES
YES
NO, duplicate
NO, collected prior to admission to facility
NO, duplicate
NO, duplicate from last specimen collection
Slide 29 from 2019 slides
45
2020 Updates for Slide 29
Update for 2020: Let’s Review!
Long-term Care Facility-onset (LO)
Resident ID
Current AdmissionDate
SpecimenCollection Date
Previous positive C. diff result date
Submit as CDI LabID Event
10 2/1/19 2/2/19 none
11 2/15/19 2/25/19 none
12 2/1/19 2/1/19 none
10 2/1/19 2/10/19 2/2/19
13 2/20/19 2/17/19 none
11 3/1/19 3/7/19 2/25/19
10 2/1/19 2/18/19 2/10/19
YES
YES
YES
YES, all CDI event must be submitted, including duplicate events
NO, collected prior to admission to facility
YES, all CDI event must be submitted, including duplicate eventsYES, all CDI event must be submitted, including duplicate events
Updated Slide 29 from 2019 slides
47
2019 Presentation, Slide 37
48
Submitting a CDI LabID Event to NHSNResident Type
Slide 37 from 2019 slides
49
2020 Updates for Slide 37
50
Submitting a CDI LabID Event to NHSN: Resident TypeUpdate for 2020
NHSN will now auto-populate Resident Type, based on the above
NHSN definitionsUpdated Slide 37 from 2019 slides
What’s New in 2020?LTCF Event Reporting: Resident Type
52
2019 Presentation, Slide 72
53
Common Terms and Definitions used in LabID Event Module
MDRO Positive Isolate: Any specimen, obtained for clinical decision making, testing that is positive for a MDRO. Note: Excludes tests related to active surveillance testing
MDRO LabID Event: A MDRO positive isolate, tested on any laboratory specimen source and the resident has no prior positive for the same organism from any specimen source collected in the same calendar month, except when a unique blood source is identified.
Applies to specimens collected in the LTCF or during brief OP visit to ED or clinic
Slide 72 from 2019 slides
54
2020 Updates for Slide 72
55
Common Terms and Definitions used in LabID Event Module
MDRO Positive Isolate: Any specimen, obtained for clinical decision making, testing that is positive for a MDRO. Note: Excludes tests related to active surveillance testing
MDRO LabID Event: MDRO Laboratory-identified (LabID) Event: (1) MDRO positive isolate collected from a resident while physically housed in the reporting LTCF at the time of specimen collection, regardless of specimen source (examples include blood, sputum, and urine); or (2) MDRO positive isolate collected from a resident during a brief outpatient visit (not admission) to an emergency department or medical office when the resident returns to the reporting LTCF on the same calendar day or the next calendar day. (see Setting).
Applies to specimens collected in the LTCF or during brief OP visit to ED or clinic
Update for 2020
Updated Slide 72 from 2019 slides
56
2019 Presentation, Slide 73
57
Common Terms and Definitions used in LabID Event Module
Unique Blood Source LabID Event: A MDRO isolate identified in a resident with no prior positive blood culture for the same MDRO in the past 2 weeks (<15 days), even across calendar months and admissions
Note: A unique blood source isolate must be reported even if the resident had this same MDRO previously isolated in a non-blood specimen earlier during the same calendar month.
Slide 73 from 2019 slides
58
2020 Updates for Slide 73
59
Common Terms and Definitions used in LabID Event Module
Unique Blood Source LabID Event: This term is no longer used in the NHSN MDRO LabID Event Module since all positive clinical specimens must be reported. However, the categorization of blood sources remains different compared to non-blood sources. See categorizations of MDRO LabID Events
Update for 2020
Updated Slide 73 from 2019 slides
60
2019 Presentation, Slide 74
61
Submit a MDRO LabID Event When.. The specimen was collected while resident was receiving care in your facility or during a brief OP
visit and returns to the LTCF on same calendar day or the next. AND…
It’s the first positive MDRO collected from any specimen source from the resident in a calendar month.
OR… It’s a positive MDRO collected from a blood culture and:
It’s the first positive MDRO from any specimen source for the resident during the calendar month, even if the resident had a prior blood reported within two weeks in the previous month
OR… If it is not the first positive for the calendar month, the resident has not had a prior positive
blood culture with the same MDRO in previous 14 days
Slide 74 from 2019 slides
62
2020 Updates for Slide 74
63
Submit a MDRO LabID Event When.. The specimen was collected while resident was receiving care in your facility or during a brief OP
visit and returns to the LTCF on same calendar day or the next.
Update for 2020
ALL positive MDRO clinical isolates must be submitted to NHSN, including
duplicate specimen sources.
Updated Slide 74 from 2019 slides
64
2019 Presentation, Slide 75
65
FIGURE 2
Slide 75 from 2019 slides
66
2020 Updates for Slide 75
67
FIGURE 2
Update for 2020
While this algorithm may be used to determine categorizations of submitted MDRO LabID Events, it is not used to determine which events should be submitted since ALL positive MDRO LabID Events must be submitted
Updated Slide 75 from 2019 slides
68
2019 Presentation, Slide 76
69
Which MDRO Specimens Should NOT be Reported to NHSN as a LabID Event?
Negative MDRO lab results
Specimens collected as part of active surveillance testing
Specimens collected during an inpatient admission in another healthcare facility
Duplicate positive results, defined as:
MDRO collected from non-blood source after the same MDRO has already been reported for the resident during the same calendar month
Resident has MDRO collected from a blood source and it’s not the first positive MDRO for the resident in the calendar month and another positive result with the same MDRO from blood has been reported in previous 14 days
Slide 76 from 2019 slides
70
2020 Updates for Slide 76
71
Which MDRO Specimens Should NOT be Reported to NHSN as a LabID Event?
Negative MDRO lab results
Specimens collected as part of active surveillance testing
Specimens collected during an inpatient admission in another healthcare facility
Update for 2020
Updated Slide 76 from 2019 slides
72
2019 Presentation, Slide 77
73
If a blood specimen is entered as the first specimen of the month, then no
non-blood specimens can be entered for the remainder of that calendar month
for that resident.
However, another blood specimen may be entered if it represents a unique
blood isolate (>2 weeks since previous same MDRO blood isolate).
Slide 77 from 2019 slides
74
2020 Updates for Slide 77
75
ALL positive MDRO clinical isolates must be submitted to NHSN, including
duplicate specimen sources.
Updated Slide 77 from 2019 slides
Update for 2020
76
2019 Presentation, Slide 78
77
EXAMPLEOn March 27, Mr. C had a positive VRE blood culture that was entered into the NHSN as a VRE LabID Event. On April 2, he had another positive VRE blood culture that was entered into the NHSN because it was the first positive VRE isolate for the new calendar month. He had a wound that also tested positive for VRE on April 20. This specimen was not entered into the NHSN since it represented a duplicate MDRO laboratory isolate for April.
Again, on April 27, Mr. C had another positive VRE blood culture. Since the isolate represented a unique blood source (>14 days since the last positive VRE blood specimen), the VRE blood specimen was submitted to the NHSN as a VRE LabID Event.
Slide 78 from 2019 slides
78
2020 Updates for Slide 78
79
EXAMPLE
On March 27, Mr. C had a positive VRE blood culture that was entered into the NHSN as a VRE LabID Event. On April 2, he had another positive VRE blood culture that was entered into the NHSN because it was the first positive VRE isolate for the new calendar month. He had a wound that also tested positive for VRE on April 20. This specimen was also not entered into the NHSN since all positive MDRO specimens must be submitted to NHSN.
Again, on April 27, Mr. C had another positive VRE blood culture. This specimen was entered into NHSN since since all positive MDRO specimens must be submitted to NHSN.
Updated Slide 78 from 2019 slides
Update for 2020
80
2019 Presentation, Slide 79
81
Let’s Review: Meet Mr. JonesAssume this is the line list for Mr. Jones and all specimens collected are shown
Current Admit Date
Specimen Collection
Date
Specimen Source
Lab Result
Report as a LabID Event?
Explanation
1 2/1/18 2/2/18 Urine MRSA
2 2/1/18 2/17/18 Wound MRSA
3 2/1/18 2/21/18 Blood MRSA
4 2/1/18 2/26/18 Blood MRSA
5 2/1/18 2/28/18 Nasal MRSA
6 2/1/18 3/1/18 Blood MRSA
7 2/1/18 3/11/18 Urine MRSA
8 2/1/18 3/14/18 Urine VRE
yes
yes
yes
no
no
no
no
1st MRSA from any specimen in calendar month
Non-blood source, prior positive MRSA isolate this calendar month
Non-blood source, prior positive MRSA isolate this calendar month
Unique blood source and no prior MRSA blood in <15 days
<15 days from previous MRSA+ blood specimen
Screening test results are excluded from LabID events
1st MRSA positive collected in new calendar month
1st VRE from any specimen in calendar monthyesSlide 79 from 2019 slides
#
82
2020 Updates for Slide 79
83
Let’s Review: Meet Mr. JonesAssume this is the line list for Mr. Jones and all specimens collected are shown
Current Admit Date
Specimen Collection
Date
Specimen Source
Lab Result
Report as a LabID Event?
Explanation
1 2/1/18 2/2/18 Urine MRSA
2 2/1/18 2/17/18 Wound MRSA
3 2/1/18 2/21/18 Blood MRSA
4 2/1/18 2/26/18 Blood MRSA
5 2/1/18 2/28/18 Nasal MRSA
6 2/1/18 3/1/18 Blood MRSA
7 2/1/18 3/11/18 Urine MRSA
8 2/1/18 3/14/18 Urine VRE
yes
yes
yes
yes
yesno
yes
All positive clinical specimen must be reported
All positive clinical specimen must be reported
All positive clinical specimen must be reported
All positive clinical specimen must be reported
All positive clinical specimen must be reported
Screening test results are excluded from LabID events
All positive clinical specimen must be reported
All positive clinical specimen must be reportedyes
Update for 2020
Updated Slide 79 from 2019 slides
#
84
2019 Presentation, Slide 80
NHSN will Categorize MDRO LabID Events for Analysis
Categorizations are determined by:
1. Reported date of current admission to facility,
2. Reported date specimen collected, and
3. Reported date of last transfer from acute care to your facility
Slide 80 from 2019 slides
86
2020 Updates for Slide 80
• All MDRO LabID Events must be submitted to NHSN. • MDRO LabID Events will be categorized, based on:
1. Reported date of current admission to facility,
2. Reported date specimen collected, and
3. Reported date of last transfer from acute care to your facility
Updated Slide 80 from 2019 slides
Update for 2020
Additional updated information from 2020 LabID Event protocol
Update for 2020
• A duplicate MDRO LabID Event will be appear in the NHSN line list and will be marked as a “duplicate” event.
• A duplicate MDRO LabID Event is defined as: (1). Any subsequent non-blood source MDRO positive isolate collected from the same resident after the first positive isolate of the same MDRO during a calendar month; or(2) Any subsequent blood source MDRO positive isolate collected from the same resident after the first positive isolate of the same MDRO during the previous two weeks (<15 calendar days), including across calendar months and admissions.
Note: if the first MDRO specimen for a calendar month is a blood source specimen, it will not be considered as a non-duplicate even if the same MDRO was reported within the previous 2 weeks.
Categorizations of MDRO LabID Events
Duplicate MDRO LabID Events MUST be reported, but are excluded from calculated rates
89
2019 Presentation, Slide 86
90
Non-duplicate MDRO LabID Events
Slide 86 from 2019 slides
91
2020 Updates for Slide 86
92
All MDRO LabID Events, includes both duplicate and non-duplicate
events
Updated Slide 86 from 2019 slides
Update for 2020
93
2019 Presentation, Slide 89
94
Submitting a CDI LabID Event to NHSNResident Type
Slide 89 from 2019 slides
95
2020 Updates for Slide 89
96
Submitting a CDI LabID Event to NHSN: Resident TypeUpdate for 2020
NHSN will now auto-populate Resident Type, based on the above
NHSN definitionsUpdated Slide 89 from 2019 slides